Variant report

Variant	nsv892688
Chromosome Location	chr9:18385143-18551247
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:18456661-18457094	HepG2	liver:	n/a	chr9:18456664-18456680
2	ARID3A	chr9:18452384-18452493	HepG2	liver:	n/a	n/a
3	ATF3	chr9:18393270-18393654	HCT-116	colon:	n/a	n/a
4	ATF3	chr9:18393238-18393764	HCT-116	colon:	n/a	n/a
5	ATF3	chr9:18393257-18393736	A549	lung:	n/a	n/a
6	BCL3	chr9:18393172-18393686	A549	lung:	n/a	n/a
7	BCL3	chr9:18393211-18393726	A549	lung:	n/a	n/a
8	BRCA1	chr9:18443194-18443410	Hela-S3	cervix:	n/a	n/a
9	BRCA1	chr9:18393063-18394411	Hela-S3	cervix:	n/a	n/a
10	BRCA1	chr9:18459902-18460682	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr9:18437528-18438248	Hela-S3	cervix:	n/a	n/a
12	CBX3	chr9:18393227-18393748	HCT-116	colon:	n/a	n/a
13	CCNT2	chr9:18404527-18404747	K562	blood:	n/a	n/a
14	CEBPB	chr9:18532530-18532635	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr9:18412122-18412353	Hela-S3	cervix:	n/a	chr9:18412243-18412254
16	CEBPB	chr9:18412239-18412301	K562	blood:	n/a	chr9:18412243-18412254
17	CEBPB	chr9:18474770-18475113	IMR90	lung:	n/a	n/a
18	CEBPB	chr9:18405291-18405586	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr9:18424133-18424479	Hela-S3	cervix:	n/a	chr9:18424300-18424313 chr9:18424302-18424311 chr9:18424301-18424312 chr9:18424300-18424313 chr9:18424300-18424311
20	CEBPB	chr9:18490482-18491371	IMR90	lung:	n/a	n/a
21	CEBPB	chr9:18429159-18429386	HepG2	liver:	n/a	chr9:18429301-18429312
22	CEBPB	chr9:18412159-18412330	H1-hESC	embryonic stem cell:	n/a	chr9:18412243-18412254
23	CEBPB	chr9:18412125-18412427	A549	lung:	n/a	chr9:18412243-18412254
24	CEBPB	chr9:18412076-18412428	IMR90	lung:	n/a	chr9:18412243-18412254
25	CEBPB	chr9:18393182-18394108	A549	lung:	n/a	chr9:18393520-18393533
26	CEBPB	chr9:18526754-18527079	IMR90	lung:	n/a	n/a
27	CEBPB	chr9:18475659-18475898	HepG2	liver:	n/a	chr9:18475780-18475791 chr9:18475780-18475793
28	CEBPB	chr9:18526762-18527049	HepG2	liver:	n/a	n/a
29	CEBPB	chr9:18393265-18393921	IMR90	lung:	n/a	chr9:18393520-18393533
30	CEBPB	chr9:18429101-18429513	IMR90	lung:	n/a	chr9:18429301-18429312
31	CEBPB	chr9:18437323-18438290	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr9:18393183-18394289	Hela-S3	cervix:	n/a	chr9:18393520-18393533
33	CEBPB	chr9:18424116-18424495	HepG2	liver:	n/a	chr9:18424300-18424313 chr9:18424302-18424311 chr9:18424301-18424312 chr9:18424300-18424313 chr9:18424300-18424311
34	CEBPB	chr9:18413205-18413242	IMR90	lung:	n/a	n/a
35	CEBPB	chr9:18472721-18473214	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr9:18475633-18475872	A549	lung:	n/a	chr9:18475780-18475791 chr9:18475780-18475793
37	CEBPB	chr9:18393319-18393654	ECC-1	luminal epithelium:	n/a	chr9:18393520-18393533
38	CEBPB	chr9:18424146-18424500	HepG2	liver:	n/a	chr9:18424300-18424313 chr9:18424302-18424311 chr9:18424301-18424312 chr9:18424300-18424313 chr9:18424300-18424311
39	CEBPB	chr9:18544401-18544745	IMR90	lung:	n/a	chr9:18544557-18544570
40	CEBPB	chr9:18393291-18393716	A549	lung:	n/a	chr9:18393520-18393533
41	CEBPB	chr9:18424148-18424384	HepG2	liver:	n/a	chr9:18424300-18424313 chr9:18424302-18424311 chr9:18424301-18424312 chr9:18424300-18424313 chr9:18424300-18424311
42	CEBPB	chr9:18526755-18527079	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr9:18424163-18424437	A549	lung:	n/a	chr9:18424300-18424313 chr9:18424302-18424311 chr9:18424301-18424312 chr9:18424300-18424313 chr9:18424300-18424311
44	CEBPB	chr9:18451400-18451709	IMR90	lung:	n/a	n/a
45	CEBPB	chr9:18451372-18451727	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr9:18502612-18502871	IMR90	lung:	n/a	chr9:18502687-18502698
47	CEBPB	chr9:18393196-18393705	HCT-116	colon:	n/a	chr9:18393520-18393533
48	CEBPB	chr9:18459956-18460360	IMR90	lung:	n/a	chr9:18460215-18460227
49	CEBPB	chr9:18475632-18475952	IMR90	lung:	n/a	chr9:18475780-18475791 chr9:18475780-18475793
50	CEBPB	chr9:18393266-18393748	A549	lung:	n/a	chr9:18393520-18393533

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:18474243-18474293	AG10803	skin:	n/a
2	chr9:18474243-18474293	AG10803	skin:	n/a
3	chr9:18473902-18473952	SK-N-SH	brain:	n/a
4	chr9:18490009-18490059	SK-N-SH	brain:	n/a
5	chr9:18514052-18514102	HPAEpiC	pulmonary alveolar:	n/a
6	chr9:18490009-18490059	LNCaP	prostate:	n/a
7	chr9:18490009-18490059	HRPEpiC	eye:	n/a
8	chr9:18514052-18514102	IMR90	lung:	fetal
9	chr9:18473902-18473952	HCF	heart:	n/a
10	chr9:18473902-18473952	LNCaP	prostate:	n/a
11	chr9:18514052-18514102	HUVEC	blood vessel:	n/a
12	chr9:18473902-18473952	HUVEC	blood vessel:	n/a
13	chr9:18473902-18473952	A549	lung:	n/a
14	chr9:18474243-18474293	ProgFib	skin:	n/a
15	chr9:18490009-18490059	IMR90	lung:	fetal
16	chr9:18473902-18473952	GM12892	blood:	n/a
17	chr9:18474243-18474293	U87	brain:	n/a
18	chr9:18474243-18474293	NHDF-neo	bronchial:	n/a
19	chr9:18514052-18514102	AoSMC	blood vessel:	n/a
20	chr9:18490009-18490059	AoSMC	blood vessel:	n/a
21	chr9:18437917-18437967	BJ	skin:	n/a
22	chr9:18490009-18490059	SK-N-MC	brain:	n/a
23	chr9:18474243-18474293	GM12891	blood:	n/a
24	chr9:18437917-18437967	NT2-D1	testis:	n/a
25	chr9:18514052-18514102	AG04450	lung:	fetal
26	chr9:18490009-18490059	HCM	heart:	n/a
27	chr9:18473902-18473952	HRCEpiC	kidney:	n/a
28	chr9:18514052-18514102	HEEpiC	esophagus:	n/a
29	chr9:18473902-18473952	MCF10A-Er-Src	breast:	n/a
30	chr9:18490009-18490059	NH-A	brain:	n/a
31	chr9:18474243-18474293	Hela-S3	cervix:	n/a
32	chr9:18514052-18514102	ovcar-3	ovarian:	n/a
33	chr9:18437917-18437967	MCF10A-Er-Src	breast:	n/a
34	chr9:18474243-18474293	HCT-116	colon:	n/a
35	chr9:18437917-18437967	HRE	kidney:	n/a
36	chr9:18437917-18437967	Jurkat	blood:	n/a
37	chr9:18490009-18490059	CMK	blood:	n/a
38	chr9:18490009-18490059	HCPEpiC	choroid plexus:	n/a
39	chr9:18490009-18490059	GM06990	blood:	n/a
40	chr9:18473902-18473952	HEK293	kidney:	embryo
41	chr9:18514052-18514102	PANC-1	pancreas:	n/a
42	chr9:18474243-18474293	ovcar-3	ovarian:	n/a
43	chr9:18437917-18437967	U87	brain:	n/a
44	chr9:18514052-18514102	GM19239	blood:	n/a
45	chr9:18437917-18437967	HCPEpiC	choroid plexus:	n/a
46	chr9:18514052-18514102	HCM	heart:	n/a
47	chr9:18490009-18490059	HCT-116	colon:	n/a
48	chr9:18490009-18490059	Caco-2	colon:	n/a
49	chr9:18490009-18490059	GM12892	blood:	n/a
50	chr9:18473902-18473952	AoSMC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:29596747..29597490-chr9:18419651..18420547,2	MCF-7	breast:
2	chr9:18436804..18438586-chr9:18439890..18441991,2	MCF-7	breast:
3	chr1:149223595..149224343-chr9:18512967..18513487,3	Hela-S3	cervix:
4	chr9:18436804..18438586-chr9:18439890..18441991,2	MCF-7	breast:
5	chr9:18254805..18255425-chr9:18442379..18443060,2	MCF-7	breast:
6	chr1:149223496..149224418-chr9:18512967..18513967,3	MCF-7	breast:
7	chr1:149222514..149224923-chr9:18513487..18514987,2	K562	blood:
8	chr10:103812339..103814566-chr9:18385028..18387430,2	MCF-7	breast:
9	chr9:18377972..18379506-chr9:18518837..18521140,2	K562	blood:
10	chr1:149223814..149224438-chr9:18512987..18513487,3	MCF-7	breast:

Variant related genes	Relation type
ADAMTSL1	TF binding region
ADAMTSL1	CpG island
ENSG00000206737	chromatin interactions

Extended variants
information (count: 6875 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:6875 , 50 per page) page: 1 2 3 4 5 6 7 ... 138

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17792334	chr9:18385143-18385144	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs557874325	chr9:18385153-18385154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs183105631	chr9:18385180-18385181	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs564739866	chr9:18385212-18385213	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs540250662	chr9:18385249-18385250	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs151198404	chr9:18385279-18385280	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs73643255	chr9:18385305-18385306	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs187884100	chr9:18385326-18385327	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs140164687	chr9:18385331-18385332	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs544091979	chr9:18385356-18385357	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs150330731	chr9:18385360-18385361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs551286185	chr9:18385369-18385370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs189706473	chr9:18385370-18385371	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs528559838	chr9:18385385-18385386	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs182737526	chr9:18385423-18385424	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs568083764	chr9:18385483-18385484	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs562392784	chr9:18385484-18385485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs187915023	chr9:18385485-18385486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs569198125	chr9:18385539-18385540	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs532175373	chr9:18385588-18385589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs192537836	chr9:18385589-18385590	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs558046767	chr9:18385597-18385598	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs566578229	chr9:18385647-18385648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs533625262	chr9:18385774-18385775	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs555406361	chr9:18385793-18385794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs137888870	chr9:18385799-18385800	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs559430702	chr9:18385863-18385864	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs544218701	chr9:18385873-18385874	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs184974082	chr9:18385889-18385890	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs556546837	chr9:18385940-18385941	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs577984393	chr9:18385956-18385957	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs34135634	chr9:18386017-18386018	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs369656843	chr9:18386035-18386036	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs560053240	chr9:18386051-18386052	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs528605802	chr9:18386053-18386054	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs540319178	chr9:18386059-18386060	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs149043561	chr9:18386084-18386085	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs188242023	chr9:18386128-18386129	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs149031454	chr9:18386143-18386144	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs138511086	chr9:18386151-18386152	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs192300620	chr9:18386191-18386192	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs573231384	chr9:18386201-18386202	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs144102768	chr9:18386205-18386206	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs566905556	chr9:18386221-18386222	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs147289459	chr9:18386275-18386276	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs552485327	chr9:18386280-18386281	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs555542976	chr9:18386302-18386303	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs567369160	chr9:18386325-18386326	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs377206084	chr9:18386342-18386343	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs561193797	chr9:18386378-18386379	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Ovarian cancer	19835627	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Melanoma	20877625	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Chordoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:2059 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:18379600-18392400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr9:18379800-18385200	Weak transcription	HSMM	muscle
3	chr9:18381000-18390200	Weak transcription	HUES48 Cell Line	embryonic stem cell
4	chr9:18382800-18386000	Weak transcription	Aorta	Aorta
5	chr9:18383200-18385200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr9:18383200-18386800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr9:18383400-18385800	Enhancers	NHDF-Ad	bronchial
8	chr9:18384400-18385200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr9:18384600-18385400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr9:18384800-18385400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr9:18384800-18386000	Enhancers	Osteobl	bone
12	chr9:18384800-18386400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr9:18384800-18386600	Enhancers	Colon Smooth Muscle	Colon
14	chr9:18384800-18386800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr9:18385000-18386000	Enhancers	Muscle Satellite Cultured Cells	--
16	chr9:18385000-18386600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr9:18385200-18386000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr9:18385200-18386400	Enhancers	HSMM	muscle
19	chr9:18385400-18390400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
20	chr9:18385600-18386200	Enhancers	HUVEC	blood vessel
21	chr9:18385800-18386400	Enhancers	Ovary	ovary
22	chr9:18385800-18386400	Flanking Active TSS	NHDF-Ad	bronchial
23	chr9:18385800-18386400	Enhancers	NHLF	lung
24	chr9:18386000-18386200	Active TSS	Aorta	Aorta
25	chr9:18386000-18386400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
26	chr9:18386000-18386400	Flanking Active TSS	Osteobl	bone
27	chr9:18386000-18390200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr9:18386200-18386400	Flanking Active TSS	Aorta	Aorta
29	chr9:18386400-18386800	Enhancers	Muscle Satellite Cultured Cells	--
30	chr9:18386400-18386800	Enhancers	NHDF-Ad	bronchial
31	chr9:18386400-18390400	Weak transcription	Ovary	ovary
32	chr9:18386400-18392800	Weak transcription	HSMM	muscle
33	chr9:18386400-18393600	Weak transcription	Aorta	Aorta
34	chr9:18386600-18390600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr9:18386800-18390200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr9:18386800-18390200	Weak transcription	NHDF-Ad	bronchial
37	chr9:18386800-18390400	Weak transcription	Muscle Satellite Cultured Cells	--
38	chr9:18388400-18388600	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr9:18388400-18388600	Enhancers	iPS-18 Cell Line	embryonic stem cell
40	chr9:18388600-18390200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
41	chr9:18388600-18393400	Weak transcription	HUES6 Cell Line	embryonic stem cell
42	chr9:18390200-18390600	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr9:18390200-18390600	Enhancers	HSMMtube	muscle
44	chr9:18390200-18390600	Flanking Active TSS	NHDF-Ad	bronchial
45	chr9:18390200-18390800	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr9:18390200-18391200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr9:18390200-18391600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr9:18390400-18390600	Enhancers	A549	lung
49	chr9:18390400-18390800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr9:18390400-18390800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links